Hematopoiesis News Volume 14.12 | March 28 2023

    0
    17








    2023-03-28 | HN 14.12


    Hematopoiesis News by STEMCELL Technologies
    Vol. 14.12 – 28 March, 2023
    TOP STORY

    Imatinib Blocks Tyrosine Phosphorylation of Smad4 and Restores TGF-β Growth-Suppressive Signaling in BCR-ABL1-Positive Leukemia

    Investigators showed that the oncogenic BCR-ABL1 of chronic myelogenous leukemia and the cellular ABL1 tyrosine kinases phosphorylated and inactivated Smad4 to block antiproliferative TGF-β signaling.
    [Signal Transduction and Targeted Therapy]

    Full Article
    Return to your lab safely and efficiently with these guides and resources so that you can focus more on moving your research goals forward.
    PUBLICATIONSRanked by the impact factor of the journal

    Toxicological Mechanism of Ammonia-N on Hematopoiesis and Apoptosis of Hemocytes in Litopenaeus vannamei

    RNA interference was performed to understand the function of astakine in hematopoiesis and apoptosis in Litopenaeus vannamei under ammonia-N exposure.
    [Science of The Total Environment]

    AbstractGraphical Abstract

    Temporal Multimodal Single-Cell Profiling of Native Hematopoiesis Illuminates Altered Differentiation Trajectories with Age

    The authors integrated extensive longitudinal functional assessments of HSC-specific lineage tracing with single-cell transcriptome and epitope profiling.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Latexin Regulates Sex Dimorphism in Hematopoiesis via Gender-Specific Differential Expression of microRNA 98–3p and Thrombospondin 1

    Scientists found no differences in HSC function and hematopoiesis in latexin (Lxn) knockout male mice under physiologic and myelosuppressive conditions. They also found that thrombospondin 1, a downstream target gene of Lxn in female HSCs, was repressed in male HSCs.
    [Cell Reports]

    Full ArticleGraphical Abstract

    ABL1 Kinase as a Tumor Suppressor in AML1-ETO and NUP98-PMX1 Leukemias

    To pinpoint mechanisms facilitating the transformation of ABL1-deficient cells, Abl1 was knocked down in 32Dcl3-Abl1ko cells by CRISPR/Cas9 followed by the challenge of growth factor withdrawal.
    [Blood Cancer Journal]

    Full Article

    pH Regulates Hematopoietic Stem Cell Potential via Polyamines

    Researchers demonstrated that the potential of murine and human HSCs was maintained when cultivated for two days ex vivo at a pH of 6.9, in contrast to cultivation at the commonly used pH of 7.4.
    [EMBO Reports]

    Full ArticleGraphical Abstract

    Atp8a1 Deletion Increases the Proliferative Activity of Hematopoietic Stem Cells by Impairing PTEN Function

    An Atp8a1 knockout mouse model was employed, from which the long-term and short-term HSC population was analyzed to assess their abundance and function.
    [Cellular Oncology]

    Abstract

    The Sinusoidal Hematopoietic Niche Is Formed by Jam1a via Notch Signaling in the Zebrafish Kidney

    Investigators demonstrated that the sinusoidal endothelium was an essential and conserved niche component in the zebrafish kidney. Histological analysis revealed that runx1:mCherry+ hematopoietic cells were predominantly detected in the dorsolateral region of the kidney.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    HDAd6/35++ – a New Helper-Dependent Adenovirus Vector Platform for In Vivo Transduction of Hematopoietic Stem Cells

    Considering the impact of anti-Ad5/HDAd5/35++ neutralizing serum antibodies present in the human population, researchers generated HSC-retargeted HDAd6/35++ vectors derived from serotype 6.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull ArticleGraphical Abstract

    Asciminib Monotherapy in Patients with CML-CP without BCR::ABL1 T315I Mutations Treated with at Least Two Prior TKIs: 4-Year Phase I Safety and Efficacy Results

    Scientists reported updated results of a Phase I, open-label, nonrandomized trial, NCT02081378, assessing the safety, tolerability, and antileukemic activity of asciminib monotherapy 10–200 mg once or twice daily in 115 patients with chromosome–positive chronic-phase chronic myeloid leukemia without T315I.
    [Leukemia]

    Full Article
    Five tips for returning to the lab after time off
    REVIEWS

    Recent Advances in Targeted Therapies in Acute Myeloid Leukemia

    The authors discuss recent updates in the classification and risk stratification of AML, explore the literature regarding low-intensity and novel oral combination therapies, and briefly highlight investigative agents currently in early clinical development for high-risk disease subtypes.
    [Journal of Hematology & Oncology]

    Full Article

    Bone Marrow Adipose Tissue: Regulation of Osteoblastic Niche, Hematopoiesis, and Hematological Malignancies

    Recent findings have identified novel progenitor subsets of bone marrow adipocytes recruited during bone marrow adipogenesis within different skeletal and HSC niches.
    [Stem Cell Reviews and Reports]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Disc Medicine Announces Collaboration with National Institutes of Health for Phase II Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA)

    Disc Medicine, Inc. announced a collaboration with the National Heart Lung and Blood Institute of the National Institutes of Health to evaluate bitopertin, a therapeutic candidate designed to modulate heme biosynthesis, in a Phase II clinical study of patients with Diamond-Blackfan anemia.
    [Disc Medicine, Inc.]

    Press Release
    FEATURED EVENT

    3D Cell Culture 2023: Models, Applications & Translation

    April 17 – 19, 2023
    Freiburg im Breisgau, Germany

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – Cancer Stem Cell Biology

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Associate – Integrated Systems Biology of AML

    University of Florida – Gainesville, Florida, United States

    Associate Research Scientists – Cancer Genetics

    Columbia University – New York City, New York, United States

    Research Assistant – Myeloid Blood Cancers

    King’s College London – Strand, England, United Kingdom

    Postdoc Scholarship – Proteomics and Leukemia

    Lund University – Lund, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter